114414-17-4

Basic information

• Product Name: 2-AMINO-3-HYDROXY-4-BROMOPYRIDINE HBR
• Synonyms: 2-AMINO-3-HYDROXY-4-BROMOPYRIDINE HBR;2-AMINO-3-HYDROXY-4-BROMOPYRIDINE HYDROBROMIDE;2-Amino-4-bromo-3-hydroxypyridine hbr;2-AMino-3-hydroxy-4-broMopydine HBr;2-AMino-4-broMopyridin-3-ol hydrobroMide;2-Amino-4-bromo-3-pyridinol monohydrobromide
• CAS NO: 114414-17-4
• Molecular Formula: BrH*C₅H₅BrN₂O
• Molecular Weight: 269.92194
• Product Categories: Pyridine
• Mol File: 114414-17-4.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: 2-AMINO-3-HYDROXY-4-BROMOPYRIDINE HBR(CAS DataBase Reference)
• NIST Chemistry Reference: 2-AMINO-3-HYDROXY-4-BROMOPYRIDINE HBR(114414-17-4)
• EPA Substance Registry System: 2-AMINO-3-HYDROXY-4-BROMOPYRIDINE HBR(114414-17-4)

Safety Data

• Hazardous Substances Data: 114414-17-4(Hazardous Substances Data)

Usage

General Description

2-Amino-3-hydroxy-4-bromopyridine HBR is a chemical compound with the molecular formula C5H6BrN2O and a molecular weight of 211.02 g/mol. It is a derivative of pyridine and contains a bromine atom, an amino group, and a hydroxy group. 2-AMINO-3-HYDROXY-4-BROMOPYRIDINE HBR can be used for various purposes, including in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds. It is also used as a building block in the production of functional materials and in research and development. Additionally, 2-Amino-3-hydroxy-4-bromopyridine HBR may have potential biological and pharmacological activities, making it of interest for further study in the fields of medicine and drug discovery.

InChI:InChI=1/C5H5BrN2O.BrH/c6-3-1-2-8-5(7)4(3)9;/h1-2,9H,(H2,7,8);1H

Upstream product

• 16867-03-1 2-amino-3-hydroxypyridine 
• 10035-10-6 hydrogen bromide 
• 7789-45-9 copper(ll) bromide 

Relevant articles and documents

POLYAROMATIC UREA DERIVATIVES AND THEIR USE IN THE TREATMENT OF MUSCLE DISEASES

The current invention provides urea derivatives, in particular compounds having the core structure heteroaryl-NH-CO-NH-aryl-O- heteroaryl, for use in treating, ameliorating, delaying, curing and/ or preventing a disease or condition associated with muscle cells and/or satellite cells, such as Duchenne muscular dystrophy, Becker muscular dystrophy, cachexia or sarcopenia.

NOVEL INHIBITORS OF MAP4K1

The invention relates to novel inhibitors of MAP4K1 (HPK1) useful for the treatment of diseases or disorders characterised by dysregulation of the signal transduction pathways associated with MAPK activation, including hyperproliferative diseases, diseases of immune system dysfunction, inflammatory disorders, neurological diseases, and cardiovascular diseases. The invention further relates to pharmaceutical compositions comprising the same and methods of treatment of said diseases and disorders. The inhibitors are of formula (I) wherein the definitions for A, D, E, F, R5, R6, R7, Z, ring Q, n, x and y are as given in the application.